Bellevue Group AG Boosts Stake in Teladoc Health, Inc. (NYSE:TDOC)

Bellevue Group AG raised its position in shares of Teladoc Health, Inc. (NYSE:TDOC) by 5.2% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 272,798 shares of the health services provider’s stock after acquiring an additional 13,394 shares during the period. Bellevue Group AG owned approximately 0.16% of Teladoc Health worth $4,119,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in the company. Parallel Advisors LLC grew its position in Teladoc Health by 14.6% during the fourth quarter. Parallel Advisors LLC now owns 4,038 shares of the health services provider’s stock valued at $87,000 after acquiring an additional 515 shares during the period. M&T Bank Corp boosted its position in shares of Teladoc Health by 5.5% in the fourth quarter. M&T Bank Corp now owns 11,152 shares of the health services provider’s stock worth $241,000 after buying an additional 584 shares during the period. Van ECK Associates Corp boosted its position in shares of Teladoc Health by 20.3% in the fourth quarter. Van ECK Associates Corp now owns 3,589 shares of the health services provider’s stock worth $77,000 after buying an additional 606 shares during the period. Ignite Planners LLC boosted its position in shares of Teladoc Health by 6.9% in the first quarter. Ignite Planners LLC now owns 13,307 shares of the health services provider’s stock worth $198,000 after buying an additional 857 shares during the period. Finally, Hexagon Capital Partners LLC lifted its stake in shares of Teladoc Health by 204.4% in the fourth quarter. Hexagon Capital Partners LLC now owns 1,586 shares of the health services provider’s stock worth $34,000 after acquiring an additional 1,065 shares in the last quarter. Hedge funds and other institutional investors own 76.82% of the company’s stock.

Insider Buying and Selling

In related news, Director Karen L. Daniel sold 9,834 shares of the firm’s stock in a transaction that occurred on Thursday, May 23rd. The stock was sold at an average price of $11.90, for a total value of $117,024.60. Following the sale, the director now owns 36,995 shares of the company’s stock, valued at approximately $440,240.50. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In related news, Director Karen L. Daniel sold 9,834 shares of the firm’s stock in a transaction that occurred on Thursday, May 23rd. The stock was sold at an average price of $11.90, for a total value of $117,024.60. Following the sale, the director now directly owns 36,995 shares in the company, valued at approximately $440,240.50. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Laizer Kornwasser sold 10,411 shares of the firm’s stock in a transaction that occurred on Thursday, May 2nd. The shares were sold at an average price of $12.69, for a total value of $132,115.59. Following the completion of the sale, the insider now owns 86,070 shares in the company, valued at $1,092,228.30. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 31,592 shares of company stock valued at $383,854. Insiders own 0.95% of the company’s stock.

Teladoc Health Stock Performance

Shares of NYSE TDOC traded up $0.12 during mid-day trading on Friday, hitting $9.37. The company had a trading volume of 5,980,905 shares, compared to its average volume of 6,725,863. The stock has a market cap of $1.59 billion, a price-to-earnings ratio of -6.65 and a beta of 0.94. Teladoc Health, Inc. has a 12 month low of $8.73 and a 12 month high of $30.41. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.82 and a quick ratio of 3.74. The firm’s 50 day simple moving average is $10.16 and its two-hundred day simple moving average is $14.01.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings results on Thursday, April 25th. The health services provider reported ($0.49) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.47) by ($0.02). The company had revenue of $646.13 million during the quarter, compared to the consensus estimate of $637.31 million. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.90%. The company’s revenue for the quarter was up 2.7% on a year-over-year basis. During the same period last year, the business posted ($0.37) EPS. As a group, equities research analysts forecast that Teladoc Health, Inc. will post -1.05 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research firms recently commented on TDOC. Oppenheimer cut their price target on Teladoc Health from $26.00 to $21.00 and set an “outperform” rating on the stock in a research note on Friday, April 26th. Stifel Nicolaus cut their price target on Teladoc Health from $21.00 to $16.00 and set a “hold” rating on the stock in a research note on Friday, April 26th. JPMorgan Chase & Co. cut their price target on Teladoc Health from $19.00 to $16.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 21st. Evercore ISI cut their price target on Teladoc Health from $14.00 to $10.00 and set an “in-line” rating on the stock in a research note on Tuesday, July 9th. Finally, Barclays cut their price objective on Teladoc Health from $25.00 to $20.00 and set an “overweight” rating on the stock in a research note on Friday, April 26th. Thirteen investment analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $17.97.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.